CH|EN
Select your region & language
Our content and services may vary by location.
CH|EN
Back
Smiling employee in a conversation with a colleague in the office
Smiling employee in a conversation with a colleague in the office
ID: 110158

Interim Chief Medical Officer

  • Pharma & Biotech
  • Asap
  • Global Strategy, Market Access, Launches
  • K-Recruiting GmbH
Contact:

Julius Strack

+49 89 1890998-21

julius.strack@k-recruiting.com

Overview

Availability
Asap; 5 days/week; on-site & remote
Qualification
English (business fluent) ,German (business fluent)
Language Skills
German (native), English (business fluent)
Relevant Expertise
Chief Medical Officer, Team Leadership, Global Strategy, Market Access, Launches, Clinical Development, R&D Integration, Organizational Transformation, Health Economics, Stakeholder Management, AI & Future Forecasting, Patient-Centric Solutions

Key-Facts

  • Global Medical & Business Strategy: Drives integration of medical, R&D, commercial, and operational strategies to deliver long-term growth and transformation

  • C-Level Leadership & Team Management: Builds, leads, and mentors large international medical and commercial teams, implementing organizational transformation and talent development

  • Innovation & Market Access: Executes global product launches, omnichannel strategies, and market-access initiatives, with experience in M&A and strategic partnerships

  • Patient-Centric & Future-Focused Solutions: Develops evidence-based, patient-focused programs and leverages AI and strategic foresight to advance healthcare innovation

Extract from Previous Activities

2024 – DATE

Healthcare Company, Germany

Chief Medical Officer

  • Oversee global medical strategy, ensuring integration with R&D, commercial, and operational objectives

  • Provide medical leadership and guidance to cross-functional teams, including clinical, regulatory, and commercial departments

  • Manage global medical affairs teams, including medical directors, scientific advisors, and field-based medical professionals

  • Build and maintain strategic relationships with external stakeholders, including key opinion leaders, academic institutions, and patient advocacy groups

  • Lead the design, execution, and oversight of clinical development programs and early-phase clinical trials

  • Drive evidence generation initiatives, including real-world data studies, health economics, and outcomes research

  • Ensure compliance with regulatory, ethical, and quality standards across all medical activities

  • Develop patient-centric solutions to address the needs of individuals affected by cancer

  • Facilitate the reduction of isolation for patients on a global scale

  • Implement a comprehensive, fully integrated framework for collaborative cancer care

  • Enable seamless collaboration among all stakeholders involved in cancer treatment

  • Drive the creation of innovative solutions that bridge gaps between research, patients, and physicians

  • Ensure alignment and synergy across all aspects of cancer care initiatives

  • Support corporate governance as a member of the executive leadership team, contributing to long-term strategy and risk management

2020 – 2024

Pharmaceutical Company, Germany

Chief Executive Officer

  • Provide expertise in international product launches to support commercial success and exceed profit goals

  • Develop and execute medical affairs programs, including support for clinical studies, project management, medical writing, launch excellence, HTA evaluations, and advisory boards

  • Apply multidisciplinary expertise in technology, AI, and strategic foresight to deliver actionable insights

  • Support organizations in adapting to an increasingly automated and AI-driven environment

2020 – 2023

Pharmaceutical Company, Germany

Vice President, Global Medical Head

  • Established, led, and directed the Global Medical Affairs function across oncology, hematology, and transplantation

  • Launched new products and evaluated innovative solutions and external acquisitions in collaboration with BD and R&D teams

  • Served as a member of the Medical Leadership Team and CEO Leadership Team, ensuring alignment of global medical strategy with long-term R&D and commercial objectives

  • Identified external opportunities and participated in due diligence processes for potential acquisitions

  • Directed the global launch of new hematology/transplant products, developing and implementing launch strategies

  • Drove successful oncology launches by executing medical, real-world evidence, and health economic strategies with cross-functional partner

  • Held full ownership of P&L for assigned franchises

  • Developed and executed global transplant franchise strategies, including lifecycle management (LCM), providing leadership and guidance across key markets

  • Collaborated closely with R&D teams on innovative earlyphase projects

  • Managed approximately 400 medical professionals globally, including Regional/Country Medical Heads, Medical Managers, Advisors, and Medical Science Liaisons across 160 countries

  • Transformed go-to-market approach through omnichannel engagement strategies

2015 – 2020

Biopharmaceutical Company, Germany

Vice President, Head of Europe Oncology

  • Structured and implemented organizational values and mission/vision statements as part of a strategic workstream

  • Directed and managed the regional Medical Affairs function across multiple countries, expanding the medical team

  • Oversaw the development, prioritization, and execution of the regional Medical Strategy, driving growth in sales and headcount

  • Led organizational transformation initiatives within the oncology division

  • Managed successful launches of key oncology products and directed pre-launch preparations for pipeline therapies

  • Contributed as a founding member of a genomics and personalized medicine research board within a public-private partnership